Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

Bullboard Posts

Comment by grosdavidon Apr 27, 2020 2:23pm

132 Views

Post# 30958681

RE:Garbage Day

Where do you see any other developments elsewhere? All I can see and hear is fear and doubt about a possible vaccine...

Last week there we two flops regarding COVID19 medecine and drugs that had more negative impacts than positive...

We are Monday 2:21 pm, what is wrong with you guys. Do I have to remember what happened last week? Traded down to 0,35$, then up to 0,54$.

Now down to 0,41$, the rest of the week will be....(someone can do the math?)....0,60$.

Shorters, weak hands, new investors, etc....part of the game.

Patience..
David

Bullboard Posts

AI companies to invest in